Liver Transplants Evaluated for Colorectal Metastases
A recent study examined survival rates and transplant outcomes for adults with unresectable colorectal liver metastases.
Updated on Oct. 13, 2026 in Cancer
Live Poll
Should specialized transplant treatments for rare cancers receive broader focus in national healthcare?
A study evaluating liver transplant outcomes for 203 adults with unresectable colorectal liver metastases found a 48.9 percent survival rate at five years. Data collected between 2017 and 2025 indicated that most post-transplant deaths were related to malignancy.
Why it matters
The findings help clarify patient selection and graft success for this complex procedure. Researchers sought to evaluate the efficacy of transplantation as a treatment option for patients with limited options.
The study included 203 participants with a mean age of 49.6 years who experienced a median waitlist time of 118 days. Patients achieved 1-year and 3-year survival rates of 90.9 percent and 69.8 percent, respectively.
The players
Scientific Registry of Transplant Recipients
This organization maintains the database of transplant clinical data used by researchers to monitor outcomes across the United States.
The details
Researchers utilized data from the Scientific Registry of Transplant Recipients for procedures conducted from 2017 to 2025. Approximately 41.4 percent of the transplanted grafts were sourced from living donors, with patients requiring a median hospital stay of 8 days.
Timeline
The study analyzed transplant procedures that occurred between 2017 and 2025.
The clinical follow-up period for the study ended in March 2026.
Health Landscape
This analysis leverages the Scientific Registry of Transplant Recipients to benchmark current success rates for liver transplantation in cancer care. It builds upon historical standards by evaluating how newer selection criteria and graft sourcing impact patient survival at the five-year mark.
Patients with unresectable colorectal liver metastases may use these survival statistics to better understand potential outcomes and surgical risks. The data highlights that while transplants are a viable option, malignancy remains a primary concern for long-term health.
The takeaway
Liver transplantation provides a potential survival pathway for patients with advanced colorectal liver metastases. Prospective patients should consult with transplant specialists to discuss how their specific medical history aligns with these survival metrics.
Further reading
For more information on current treatment trends, visit the Cancer section.
Source note: This article includes information reported by Healio.
Live Poll
Should specialized transplant treatments for rare cancers receive broader focus in national healthcare?
